ConductScience.org, home

Paper21898546

The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.

King TD and 2 others. J Cell Biochem, 2012. Cited by 245 papers, by iCite.

Cite this record

ConductScience Library. The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer. Papers, record 21898546. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21898546

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.
PubMed
Journal
J Cell Biochem
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Review
PubMed
Citations, by iCite
245
iCite
Relative citation ratio, by iCite
6.88
iCite
Revised in PubMed
2026-01-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1King TDTaj D
2Suto MJMark J
3Li YYonghe

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Frizzled ReceptorsMajor topic
Low Density Lipoprotein Receptor-Related Protein-6Major topic
Wnt Signaling PathwayMajor topic
Cell Proliferation
Female
Humans
Pyrans
Erb-b2 Receptor Tyrosine Kinases
Receptors, Estrogen
Receptors, Progesterone
Polyether Polyketides

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA124531NCI NIH HHSUnited StatesR01CA124531PubMed and NIH
R01CA124531NCI NIH HHSUnited StatesR01CA124531PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117468756MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer.Nat Genet2007https://conductscience.org/library/papers/17468756PubMed
218559090The CD44+/CD24- phenotype is enriched in basal-like breast tumors.Breast Cancer Res2008https://conductscience.org/library/papers/18559090PubMed
319619488Wnt/beta-catenin signaling: components, mechanisms, and diseases.Dev Cell2009https://conductscience.org/library/papers/19619488PubMed
412629218Prospective identification of tumorigenic breast cancer cells.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12629218PubMed
520877296Triple-negative breast cancer: disease entity or title of convenience?Nat Rev Clin Oncol2010https://conductscience.org/library/papers/20877296PubMed
619503830The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development.PLoS One2009https://conductscience.org/library/papers/19503830PubMed
721835542Salinomycin inhibits osteosarcoma by targeting its tumor stem cells.Cancer Lett2011https://conductscience.org/library/papers/21835542PubMed
814739782Wnt signaling and breast cancer.Cancer Biol Ther2004https://conductscience.org/library/papers/14739782PubMed
920395444Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.Am J Pathol2010https://conductscience.org/library/papers/20395444PubMed
1018398311Epigenetic gene silencing in the Wnt pathway in breast cancer.Epigenetics2008https://conductscience.org/library/papers/18398311PubMed
1119473496WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.Breast Cancer Res2009https://conductscience.org/library/papers/19473496PubMed
1216357527R-Spondin proteins: a novel link to beta-catenin activation.Cell Cycle2006https://conductscience.org/library/papers/16357527PubMed
133180222Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice.Cell1988https://conductscience.org/library/papers/3180222PubMed
1420194742LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20194742PubMed
1516263759Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding.J Cell Sci2005https://conductscience.org/library/papers/16263759PubMed
1621727895Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling.Nature2011https://conductscience.org/library/papers/21727895PubMed
1721788521Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21788521PubMed
1818283316Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer.Br J Cancer2008https://conductscience.org/library/papers/18283316PubMed
1919682730Identification of selective inhibitors of cancer stem cells by high-throughput screening.Cell2009https://conductscience.org/library/papers/19682730PubMed
2019672307The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage.PLoS One2009https://conductscience.org/library/papers/19672307PubMed

See all 49 referencesDownload CSV of references

Cited by173

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 245 citations.

PMIDTitleJournalYearIn PapersSource
42589239The Molecular Structure, Expression, and Emerging Role of the 15-Leucine-Rich Repeat Containing Membrane Protein (LRRC15) in Skeletal Biology and Diseases.Int J Mol Sci2026https://conductscience.org/library/papers/42589239PubMed
42570972Escherichia coli DH5α-loaded fenugreek extract: an effective anticancer combination against human breast cancer cell lines.Appl Microbiol Biotechnol2026https://conductscience.org/library/papers/42570972PubMed
42100345The role of pluripotency regulators in triple-negative breast cancer immune response.Front Genet2026https://conductscience.org/library/papers/42100345PubMed
41696244Loading Density Influences the Tumor Cell Targeting and Signaling Inhibition Capabilities of Antibody Nanoconjugates.ACS Omega2026https://conductscience.org/library/papers/41696244PubMed
41524847Wnt ligands in breast cancer metastasis: unraveling their dual roles and therapeutic potential.Mol Biol Rep2026https://conductscience.org/library/papers/41524847PubMed
41150754Monitoring Pharmacological Treatment of Breast Cancer with MRI.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41150754PubMed
41069341Therapeutic innovations in triple negative breast cancer: integrating molecular targeting and monoclonal antibody strategies.Front Oncol2025https://conductscience.org/library/papers/41069341PubMed
40913249Exacerbation of paclitaxel-induced neuropathic pain behaviors in breast tumor-bearing mice.Mol Pain2025https://conductscience.org/library/papers/40913249PubMed
40851994Hypoxia-driven angiogenesis in breast cancer mechanisms and therapeutic targets: a narrative review.Ann Med Surg (Lond)2025https://conductscience.org/library/papers/40851994PubMed
40804731Regulatory roles of circular RNAs in Wnt and other oncogenic signaling pathways in breast cancer progression: a comprehensive review.Eur J Med Res2025https://conductscience.org/library/papers/40804731PubMed
40730501Bufalin Suppresses Triple-Negative Breast Cancer Stem Cell Growth by Inhibiting the Wnt/β-Catenin Signaling Pathway.J Microbiol Biotechnol2025https://conductscience.org/library/papers/40730501PubMed
40719975The effect of dendrosomal nanocurcumin on Wnt/β-catenin signaling pathway via PIWIL2 in MCF-7 breast cancer cells.Med Oncol2025https://conductscience.org/library/papers/40719975PubMed
40486584Oxygen deprivation in breast cancer: mechanisms, pathways, and implications.Ann Med Surg (Lond)2025https://conductscience.org/library/papers/40486584PubMed
40285986NSAID-encapsulated nanoparticles as a targeted therapeutic platform for modulating chronic inflammation and inhibiting cancer progression: a review.Inflammopharmacology2025https://conductscience.org/library/papers/40285986PubMed
40093866ALDH1A1 in breast cancer: A prospective target to overcome therapy resistance (Review).Oncol Lett2025https://conductscience.org/library/papers/40093866PubMed
39882028Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention in Women at High Risk of Cancer.Int J Breast Cancer2025https://conductscience.org/library/papers/39882028PubMed
39461917MicroRNA-205-5p inhibits the growth and migration of breast cancer through targeting Wnt/β-catenin co-receptor LRP6 and interacting with lncRNAs.Mol Cell Biochem2025https://conductscience.org/library/papers/39461917PubMed
39006318Antibody and siRNA Nanocarriers to Suppress Wnt Signaling, Tumor Growth, and Lung Metastasis in Triple-Negative Breast Cancer.Adv Ther (Weinh)2024https://conductscience.org/library/papers/39006318PubMed
38999849Intermittent Fasting Attenuates Obesity-Induced Triple-Negative Breast Cancer Progression by Disrupting Cell Cycle, Epithelial-Mesenchymal Transition, Immune Contexture, and Proinflammatory Signature.Nutrients2024https://conductscience.org/library/papers/38999849PubMed
38292186The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities.Genes Dis2024https://conductscience.org/library/papers/38292186PubMed

See all 173 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
FZD18321PubTator's text mininghttps://conductscience.org/library/genes/8321NCBI Gene
FZD78324PubTator's text mininghttps://conductscience.org/library/genes/8324NCBI Gene
LRP64040PubTator's text mininghttps://conductscience.org/library/genes/4040NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21898546

GET https://conductscience.org/api/papers/v1/21898546/references?page=2